Global Thyroid Cancer Testing Market Growth (Status and Outlook) 2026-2032

October 2026 | 122 pages | ID: G8CB7F3442D4EN
LP Information

Abstracts

The global Thyroid Cancer Testing market size is predicted to grow from US$ 1917 million in 2025 to US$ 3373 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032.

The gross profit margin of major companies in the industry was approximately 45%–65%.

Thyroid Cancer Testing includes diagnostic assays and laboratory methods used to identify, classify, and assess thyroid malignancies and suspicious thyroid nodules. Testing may include cytology-supported molecular assays, gene mutation panels, gene expression classifiers, protein biomarkers, immunoassays, and other molecular diagnostic techniques. These tests support diagnosis, risk stratification, treatment selection, and follow-up and are increasingly used alongside ultrasound, fine-needle aspiration, pathology, and other clinical evaluation methods.

The industrial chain of Thyroid Cancer Testing includes upstream antibodies, primers, probes, sequencing reagents, enzymes, biomarkers, diagnostic instruments, sample-preparation products, and software; midstream covers assay development, diagnostic kit production, laboratory testing, sequencing, molecular analysis, validation, data interpretation, and quality control; downstream applications mainly include hospitals, pathology laboratories, molecular diagnostic laboratories, cancer centers, endocrinology clinics, and research institutions.

Thyroid cancer testing includes diagnostic methods used to identify, characterize, and support clinical management of suspected thyroid malignancies, including cytology, laboratory testing, molecular diagnostics, and related testing technologies. Market demand is supported by increasing detection of thyroid nodules, wider use of imaging examinations, greater awareness of thyroid disease, and growing demand for more accurate differentiation between benign and malignant lesions. Technology development is increasingly focused on molecular biomarkers, mutation analysis, gene-expression profiling, and combined interpretation of multiple diagnostic indicators. Molecular testing is particularly valuable for indeterminate thyroid nodules where conventional cytology cannot provide a definitive diagnosis. Precision oncology and personalized treatment planning also increase demand for more detailed molecular characterization. However, advanced testing costs, differences in clinical guidelines, reimbursement limitations, variable access to molecular diagnostics, and concerns regarding overdiagnosis can constrain market expansion. Future development will emphasize diagnostic accuracy, risk stratification, minimally invasive testing, standardized molecular interpretation, and closer integration of laboratory, imaging, and clinical information.

Report Scope

LPI (LP Information)' newest research report, the “Thyroid Cancer Testing Industry Forecast” looks at past sales and reviews total world Thyroid Cancer Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Thyroid Cancer Testing sales for 2026 through 2032. With Thyroid Cancer Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thyroid Cancer Testing industry.

This Insight Report provides a comprehensive analysis of the global Thyroid Cancer Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Thyroid Cancer Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Thyroid Cancer Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thyroid Cancer Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thyroid Cancer Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Thyroid Cancer Testing market by product type, application, key players and key regions and countries.

Market Segmentation

Segmentation by Type:

• Cytology and Histopathology Testing
• Molecular Genetic Testing
• Protein Biomarker and Immunological Testing

Segmentation by Specimen Type:

• Fine-needle Aspiration Samples
• Surgical Tissue Samples
• Blood and Other Liquid Samples

Segmentation by Turnaround Time:

• Rapid Testing??24 Hours?
• Standard Testing??24 Hours–7 Days?
• Extended Testing??7 Days?

Segmentation by Application:

• Malignancy Diagnosis
• Indeterminate Nodule Risk Stratification
• Treatment Selection and Recurrence Monitoring
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Veracyte, Inc.
• Sonic Healthcare USA, Inc. / ThyroSeq
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• Abbott Laboratories
• Siemens Healthineers AG
• Beckman Coulter, Inc.
• Fujirebio Holdings, Inc.
• Sysmex Corporation
• Asuragen, Inc. / Bio-Techne Corporation
• Illumina, Inc.
• Amoy Diagnostics Co., Ltd.
• Burning Rock Biotech Limited
• Berry Oncology Corporation
• BGI Genomics Co., Ltd.
• Sansure Biotech Inc.
• Tellgen Corporation

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Thyroid Cancer Testing Market Size (2021-2032)
  2.1.2 Thyroid Cancer Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Thyroid Cancer Testing by Country/Region (2021, 2025 & 2032)
2.2 Thyroid Cancer Testing Segment by Type
  2.2.1 Cytology and Histopathology Testing
  2.2.2 Molecular Genetic Testing
  2.2.3 Protein Biomarker and Immunological Testing
  2.2.4 Thyroid Cancer Testing Market Size by Type
    2.2.4.1 Thyroid Cancer Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Thyroid Cancer Testing Market Size Market Share by Type (2021-2026)
2.3 Thyroid Cancer Testing Segment by Specimen Type
  2.3.1 Fine-needle Aspiration Samples
  2.3.2 Surgical Tissue Samples
  2.3.3 Blood and Other Liquid Samples
  2.3.4 Thyroid Cancer Testing Market Size by Specimen Type
    2.3.4.1 Thyroid Cancer Testing Market Size CAGR by Specimen Type (2021 VS 2025 VS 2032)
    2.3.4.2 Global Thyroid Cancer Testing Market Size Market Share by Specimen Type (2021-2026)
2.4 Thyroid Cancer Testing Segment by Turnaround Time
  2.4.1 Rapid Testing??24 Hours?
  2.4.2 Standard Testing??24 Hours–7 Days?
  2.4.3 Extended Testing??7 Days?
  2.4.4 Thyroid Cancer Testing Market Size by Turnaround Time
    2.4.4.1 Thyroid Cancer Testing Market Size CAGR by Turnaround Time (2021 VS 2025 VS 2032)
    2.4.4.2 Global Thyroid Cancer Testing Market Size Market Share by Turnaround Time (2021-2026)
2.5 Thyroid Cancer Testing Segment by Application
  2.5.1 Malignancy Diagnosis
  2.5.2 Indeterminate Nodule Risk Stratification
  2.5.3 Treatment Selection and Recurrence Monitoring
  2.5.4 Other
  2.5.5 Thyroid Cancer Testing Market Size by Application
    2.5.5.1 Thyroid Cancer Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.5.5.2 Global Thyroid Cancer Testing Market Size Market Share by Application (2021-2026)

3 THYROID CANCER TESTING MARKET SIZE BY PLAYER

3.1 Thyroid Cancer Testing Market Size Market Share by Player
  3.1.1 Global Thyroid Cancer Testing Revenue by Player (2021-2026)
  3.1.2 Global Thyroid Cancer Testing Revenue Market Share by Player (2021-2026)
3.2 Global Thyroid Cancer Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 THYROID CANCER TESTING BY REGION

4.1 Thyroid Cancer Testing Market Size by Region (2021-2026)
4.2 Global Thyroid Cancer Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Thyroid Cancer Testing Market Size Growth (2021-2026)
4.4 APAC Thyroid Cancer Testing Market Size Growth (2021-2026)
4.5 Europe Thyroid Cancer Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Thyroid Cancer Testing Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Thyroid Cancer Testing Market Size by Country (2021-2026)
5.2 Americas Thyroid Cancer Testing Market Size by Type (2021-2026)
5.3 Americas Thyroid Cancer Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Thyroid Cancer Testing Market Size by Region (2021-2026)
6.2 APAC Thyroid Cancer Testing Market Size by Type (2021-2026)
6.3 APAC Thyroid Cancer Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Thyroid Cancer Testing Market Size by Country (2021-2026)
7.2 Europe Thyroid Cancer Testing Market Size by Type (2021-2026)
7.3 Europe Thyroid Cancer Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Thyroid Cancer Testing by Region (2021-2026)
8.2 Middle East & Africa Thyroid Cancer Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Thyroid Cancer Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL THYROID CANCER TESTING MARKET FORECAST

10.1 Global Thyroid Cancer Testing Forecast by Region (2027-2032)
  10.1.1 Global Thyroid Cancer Testing Forecast by Region (2027-2032)
  10.1.2 Americas Thyroid Cancer Testing Forecast
  10.1.3 APAC Thyroid Cancer Testing Forecast
  10.1.4 Europe Thyroid Cancer Testing Forecast
  10.1.5 Middle East & Africa Thyroid Cancer Testing Forecast
10.2 Americas Thyroid Cancer Testing Forecast by Country (2027-2032)
  10.2.1 United States Market Thyroid Cancer Testing Forecast
  10.2.2 Canada Market Thyroid Cancer Testing Forecast
  10.2.3 Mexico Market Thyroid Cancer Testing Forecast
  10.2.4 Brazil Market Thyroid Cancer Testing Forecast
10.3 APAC Thyroid Cancer Testing Forecast by Region (2027-2032)
  10.3.1 China Thyroid Cancer Testing Market Forecast
  10.3.2 Japan Market Thyroid Cancer Testing Forecast
  10.3.3 Korea Market Thyroid Cancer Testing Forecast
  10.3.4 Southeast Asia Market Thyroid Cancer Testing Forecast
  10.3.5 India Market Thyroid Cancer Testing Forecast
  10.3.6 Australia Market Thyroid Cancer Testing Forecast
10.4 Europe Thyroid Cancer Testing Forecast by Country (2027-2032)
  10.4.1 Germany Market Thyroid Cancer Testing Forecast
  10.4.2 France Market Thyroid Cancer Testing Forecast
  10.4.3 UK Market Thyroid Cancer Testing Forecast
  10.4.4 Italy Market Thyroid Cancer Testing Forecast
  10.4.5 Russia Market Thyroid Cancer Testing Forecast
10.5 Middle East & Africa Thyroid Cancer Testing Forecast by Region (2027-2032)
  10.5.1 Egypt Market Thyroid Cancer Testing Forecast
  10.5.2 South Africa Market Thyroid Cancer Testing Forecast
  10.5.3 Israel Market Thyroid Cancer Testing Forecast
  10.5.4 Turkey Market Thyroid Cancer Testing Forecast
10.6 Global Thyroid Cancer Testing Forecast by Type (2027-2032)
10.7 Global Thyroid Cancer Testing Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Thyroid Cancer Testing Forecast

11 KEY PLAYERS ANALYSIS

11.1 Veracyte, Inc.
  11.1.1 Veracyte, Inc. Company Information
  11.1.2 Veracyte, Inc. Thyroid Cancer Testing Product Offered
  11.1.3 Veracyte, Inc. Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Veracyte, Inc. Main Business Overview
  11.1.5 Veracyte, Inc. Latest Developments
11.2 Sonic Healthcare USA, Inc. / ThyroSeq
  11.2.1 Sonic Healthcare USA, Inc. / ThyroSeq Company Information
  11.2.2 Sonic Healthcare USA, Inc. / ThyroSeq Thyroid Cancer Testing Product Offered
  11.2.3 Sonic Healthcare USA, Inc. / ThyroSeq Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Sonic Healthcare USA, Inc. / ThyroSeq Main Business Overview
  11.2.5 Sonic Healthcare USA, Inc. / ThyroSeq Latest Developments
11.3 F. Hoffmann-La Roche Ltd.
  11.3.1 F. Hoffmann-La Roche Ltd. Company Information
  11.3.2 F. Hoffmann-La Roche Ltd. Thyroid Cancer Testing Product Offered
  11.3.3 F. Hoffmann-La Roche Ltd. Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 F. Hoffmann-La Roche Ltd. Main Business Overview
  11.3.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.4 Thermo Fisher Scientific Inc.
  11.4.1 Thermo Fisher Scientific Inc. Company Information
  11.4.2 Thermo Fisher Scientific Inc. Thyroid Cancer Testing Product Offered
  11.4.3 Thermo Fisher Scientific Inc. Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Thermo Fisher Scientific Inc. Main Business Overview
  11.4.5 Thermo Fisher Scientific Inc. Latest Developments
11.5 QIAGEN N.V.
  11.5.1 QIAGEN N.V. Company Information
  11.5.2 QIAGEN N.V. Thyroid Cancer Testing Product Offered
  11.5.3 QIAGEN N.V. Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 QIAGEN N.V. Main Business Overview
  11.5.5 QIAGEN N.V. Latest Developments
11.6 Abbott Laboratories
  11.6.1 Abbott Laboratories Company Information
  11.6.2 Abbott Laboratories Thyroid Cancer Testing Product Offered
  11.6.3 Abbott Laboratories Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Abbott Laboratories Main Business Overview
  11.6.5 Abbott Laboratories Latest Developments
11.7 Siemens Healthineers AG
  11.7.1 Siemens Healthineers AG Company Information
  11.7.2 Siemens Healthineers AG Thyroid Cancer Testing Product Offered
  11.7.3 Siemens Healthineers AG Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Siemens Healthineers AG Main Business Overview
  11.7.5 Siemens Healthineers AG Latest Developments
11.8 Beckman Coulter, Inc.
  11.8.1 Beckman Coulter, Inc. Company Information
  11.8.2 Beckman Coulter, Inc. Thyroid Cancer Testing Product Offered
  11.8.3 Beckman Coulter, Inc. Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Beckman Coulter, Inc. Main Business Overview
  11.8.5 Beckman Coulter, Inc. Latest Developments
11.9 Fujirebio Holdings, Inc.
  11.9.1 Fujirebio Holdings, Inc. Company Information
  11.9.2 Fujirebio Holdings, Inc. Thyroid Cancer Testing Product Offered
  11.9.3 Fujirebio Holdings, Inc. Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Fujirebio Holdings, Inc. Main Business Overview
  11.9.5 Fujirebio Holdings, Inc. Latest Developments
11.10 Sysmex Corporation
  11.10.1 Sysmex Corporation Company Information
  11.10.2 Sysmex Corporation Thyroid Cancer Testing Product Offered
  11.10.3 Sysmex Corporation Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Sysmex Corporation Main Business Overview
  11.10.5 Sysmex Corporation Latest Developments
11.11 Asuragen, Inc. / Bio-Techne Corporation
  11.11.1 Asuragen, Inc. / Bio-Techne Corporation Company Information
  11.11.2 Asuragen, Inc. / Bio-Techne Corporation Thyroid Cancer Testing Product Offered
  11.11.3 Asuragen, Inc. / Bio-Techne Corporation Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Asuragen, Inc. / Bio-Techne Corporation Main Business Overview
  11.11.5 Asuragen, Inc. / Bio-Techne Corporation Latest Developments
11.12 Illumina, Inc.
  11.12.1 Illumina, Inc. Company Information
  11.12.2 Illumina, Inc. Thyroid Cancer Testing Product Offered
  11.12.3 Illumina, Inc. Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 Illumina, Inc. Main Business Overview
  11.12.5 Illumina, Inc. Latest Developments
11.13 Amoy Diagnostics Co., Ltd.
  11.13.1 Amoy Diagnostics Co., Ltd. Company Information
  11.13.2 Amoy Diagnostics Co., Ltd. Thyroid Cancer Testing Product Offered
  11.13.3 Amoy Diagnostics Co., Ltd. Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Amoy Diagnostics Co., Ltd. Main Business Overview
  11.13.5 Amoy Diagnostics Co., Ltd. Latest Developments
11.14 Burning Rock Biotech Limited
  11.14.1 Burning Rock Biotech Limited Company Information
  11.14.2 Burning Rock Biotech Limited Thyroid Cancer Testing Product Offered
  11.14.3 Burning Rock Biotech Limited Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 Burning Rock Biotech Limited Main Business Overview
  11.14.5 Burning Rock Biotech Limited Latest Developments
11.15 Berry Oncology Corporation
  11.15.1 Berry Oncology Corporation Company Information
  11.15.2 Berry Oncology Corporation Thyroid Cancer Testing Product Offered
  11.15.3 Berry Oncology Corporation Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Berry Oncology Corporation Main Business Overview
  11.15.5 Berry Oncology Corporation Latest Developments
11.16 BGI Genomics Co., Ltd.
  11.16.1 BGI Genomics Co., Ltd. Company Information
  11.16.2 BGI Genomics Co., Ltd. Thyroid Cancer Testing Product Offered
  11.16.3 BGI Genomics Co., Ltd. Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 BGI Genomics Co., Ltd. Main Business Overview
  11.16.5 BGI Genomics Co., Ltd. Latest Developments
11.17 Sansure Biotech Inc.
  11.17.1 Sansure Biotech Inc. Company Information
  11.17.2 Sansure Biotech Inc. Thyroid Cancer Testing Product Offered
  11.17.3 Sansure Biotech Inc. Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 Sansure Biotech Inc. Main Business Overview
  11.17.5 Sansure Biotech Inc. Latest Developments
11.18 Tellgen Corporation
  11.18.1 Tellgen Corporation Company Information
  11.18.2 Tellgen Corporation Thyroid Cancer Testing Product Offered
  11.18.3 Tellgen Corporation Thyroid Cancer Testing Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 Tellgen Corporation Main Business Overview
  11.18.5 Tellgen Corporation Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Thyroid Cancer Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Thyroid Cancer Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cytology and Histopathology Testing
Table 4. Major Players of Molecular Genetic Testing
Table 5. Major Players of Protein Biomarker and Immunological Testing
Table 6. Thyroid Cancer Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Thyroid Cancer Testing Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Thyroid Cancer Testing Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Fine-needle Aspiration Samples
Table 10. Major Players of Surgical Tissue Samples
Table 11. Major Players of Blood and Other Liquid Samples
Table 12. Thyroid Cancer Testing Market Size CAGR by Specimen Type (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Thyroid Cancer Testing Market Size by Specimen Type (2021-2026) & ($ millions)
Table 14. Global Thyroid Cancer Testing Market Size Market Share by Specimen Type (2021-2026)
Table 15. Major Players of Rapid Testing??24 Hours?
Table 16. Major Players of Standard Testing??24 Hours–7 Days?
Table 17. Major Players of Extended Testing??7 Days?
Table 18. Thyroid Cancer Testing Market Size CAGR by Turnaround Time (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Thyroid Cancer Testing Market Size by Turnaround Time (2021-2026) & ($ millions)
Table 20. Global Thyroid Cancer Testing Market Size Market Share by Turnaround Time (2021-2026)
Table 21. Thyroid Cancer Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Thyroid Cancer Testing Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Thyroid Cancer Testing Market Size Market Share by Application (2021-2026)
Table 24. Global Thyroid Cancer Testing Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Thyroid Cancer Testing Revenue Market Share by Player (2021-2026)
Table 26. Thyroid Cancer Testing Key Players Head office and Products Offered
Table 27. Thyroid Cancer Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Thyroid Cancer Testing Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Thyroid Cancer Testing Market Size Market Share by Region (2021-2026)
Table 32. Global Thyroid Cancer Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Thyroid Cancer Testing Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Thyroid Cancer Testing Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Thyroid Cancer Testing Market Size Market Share by Country (2021-2026)
Table 36. Americas Thyroid Cancer Testing Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Thyroid Cancer Testing Market Size Market Share by Type (2021-2026)
Table 38. Americas Thyroid Cancer Testing Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Thyroid Cancer Testing Market Size Market Share by Application (2021-2026)
Table 40. APAC Thyroid Cancer Testing Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Thyroid Cancer Testing Market Size Market Share by Region (2021-2026)
Table 42. APAC Thyroid Cancer Testing Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Thyroid Cancer Testing Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Thyroid Cancer Testing Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Thyroid Cancer Testing Market Size Market Share by Country (2021-2026)
Table 46. Europe Thyroid Cancer Testing Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Thyroid Cancer Testing Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Thyroid Cancer Testing Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Thyroid Cancer Testing Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Thyroid Cancer Testing Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Thyroid Cancer Testing
Table 52. Key Market Challenges & Risks of Thyroid Cancer Testing
Table 53. Key Industry Trends of Thyroid Cancer Testing
Table 54. Global Thyroid Cancer Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Thyroid Cancer Testing Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Thyroid Cancer Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Thyroid Cancer Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Veracyte, Inc. Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 59. Veracyte, Inc. Thyroid Cancer Testing Product Offered
Table 60. Veracyte, Inc. Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Veracyte, Inc. Main Business
Table 62. Veracyte, Inc. Latest Developments
Table 63. Sonic Healthcare USA, Inc. / ThyroSeq Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 64. Sonic Healthcare USA, Inc. / ThyroSeq Thyroid Cancer Testing Product Offered
Table 65. Sonic Healthcare USA, Inc. / ThyroSeq Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Sonic Healthcare USA, Inc. / ThyroSeq Main Business
Table 67. Sonic Healthcare USA, Inc. / ThyroSeq Latest Developments
Table 68. F. Hoffmann-La Roche Ltd. Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 69. F. Hoffmann-La Roche Ltd. Thyroid Cancer Testing Product Offered
Table 70. F. Hoffmann-La Roche Ltd. Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. F. Hoffmann-La Roche Ltd. Main Business
Table 72. F. Hoffmann-La Roche Ltd. Latest Developments
Table 73. Thermo Fisher Scientific Inc. Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 74. Thermo Fisher Scientific Inc. Thyroid Cancer Testing Product Offered
Table 75. Thermo Fisher Scientific Inc. Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Thermo Fisher Scientific Inc. Main Business
Table 77. Thermo Fisher Scientific Inc. Latest Developments
Table 78. QIAGEN N.V. Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 79. QIAGEN N.V. Thyroid Cancer Testing Product Offered
Table 80. QIAGEN N.V. Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. QIAGEN N.V. Main Business
Table 82. QIAGEN N.V. Latest Developments
Table 83. Abbott Laboratories Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 84. Abbott Laboratories Thyroid Cancer Testing Product Offered
Table 85. Abbott Laboratories Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Abbott Laboratories Main Business
Table 87. Abbott Laboratories Latest Developments
Table 88. Siemens Healthineers AG Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 89. Siemens Healthineers AG Thyroid Cancer Testing Product Offered
Table 90. Siemens Healthineers AG Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Siemens Healthineers AG Main Business
Table 92. Siemens Healthineers AG Latest Developments
Table 93. Beckman Coulter, Inc. Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 94. Beckman Coulter, Inc. Thyroid Cancer Testing Product Offered
Table 95. Beckman Coulter, Inc. Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Beckman Coulter, Inc. Main Business
Table 97. Beckman Coulter, Inc. Latest Developments
Table 98. Fujirebio Holdings, Inc. Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 99. Fujirebio Holdings, Inc. Thyroid Cancer Testing Product Offered
Table 100. Fujirebio Holdings, Inc. Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Fujirebio Holdings, Inc. Main Business
Table 102. Fujirebio Holdings, Inc. Latest Developments
Table 103. Sysmex Corporation Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 104. Sysmex Corporation Thyroid Cancer Testing Product Offered
Table 105. Sysmex Corporation Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Sysmex Corporation Main Business
Table 107. Sysmex Corporation Latest Developments
Table 108. Asuragen, Inc. / Bio-Techne Corporation Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 109. Asuragen, Inc. / Bio-Techne Corporation Thyroid Cancer Testing Product Offered
Table 110. Asuragen, Inc. / Bio-Techne Corporation Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Asuragen, Inc. / Bio-Techne Corporation Main Business
Table 112. Asuragen, Inc. / Bio-Techne Corporation Latest Developments
Table 113. Illumina, Inc. Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 114. Illumina, Inc. Thyroid Cancer Testing Product Offered
Table 115. Illumina, Inc. Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Illumina, Inc. Main Business
Table 117. Illumina, Inc. Latest Developments
Table 118. Amoy Diagnostics Co., Ltd. Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 119. Amoy Diagnostics Co., Ltd. Thyroid Cancer Testing Product Offered
Table 120. Amoy Diagnostics Co., Ltd. Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Amoy Diagnostics Co., Ltd. Main Business
Table 122. Amoy Diagnostics Co., Ltd. Latest Developments
Table 123. Burning Rock Biotech Limited Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 124. Burning Rock Biotech Limited Thyroid Cancer Testing Product Offered
Table 125. Burning Rock Biotech Limited Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Burning Rock Biotech Limited Main Business
Table 127. Burning Rock Biotech Limited Latest Developments
Table 128. Berry Oncology Corporation Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 129. Berry Oncology Corporation Thyroid Cancer Testing Product Offered
Table 130. Berry Oncology Corporation Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Berry Oncology Corporation Main Business
Table 132. Berry Oncology Corporation Latest Developments
Table 133. BGI Genomics Co., Ltd. Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 134. BGI Genomics Co., Ltd. Thyroid Cancer Testing Product Offered
Table 135. BGI Genomics Co., Ltd. Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. BGI Genomics Co., Ltd. Main Business
Table 137. BGI Genomics Co., Ltd. Latest Developments
Table 138. Sansure Biotech Inc. Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 139. Sansure Biotech Inc. Thyroid Cancer Testing Product Offered
Table 140. Sansure Biotech Inc. Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Sansure Biotech Inc. Main Business
Table 142. Sansure Biotech Inc. Latest Developments
Table 143. Tellgen Corporation Details, Company Type, Thyroid Cancer Testing Area Served and Its Competitors
Table 144. Tellgen Corporation Thyroid Cancer Testing Product Offered
Table 145. Tellgen Corporation Thyroid Cancer Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Tellgen Corporation Main Business
Table 147. Tellgen Corporation Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Thyroid Cancer Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Thyroid Cancer Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Thyroid Cancer Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Thyroid Cancer Testing Sales Market Share by Country/Region (2025)
Figure 8. Thyroid Cancer Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Thyroid Cancer Testing Market Size Market Share by Type in 2025
Figure 10. Global Thyroid Cancer Testing Market Size Market Share by Specimen Type in 2025
Figure 11. Global Thyroid Cancer Testing Market Size Market Share by Turnaround Time in 2025
Figure 12. Thyroid Cancer Testing in Malignancy Diagnosis
Figure 13. Global Thyroid Cancer Testing Market: Malignancy Diagnosis (2021-2026) & ($ millions)
Figure 14. Thyroid Cancer Testing in Indeterminate Nodule Risk Stratification
Figure 15. Global Thyroid Cancer Testing Market: Indeterminate Nodule Risk Stratification (2021-2026) & ($ millions)
Figure 16. Thyroid Cancer Testing in Treatment Selection and Recurrence Monitoring
Figure 17. Global Thyroid Cancer Testing Market: Treatment Selection and Recurrence Monitoring (2021-2026) & ($ millions)
Figure 18. Thyroid Cancer Testing in Other
Figure 19. Global Thyroid Cancer Testing Market: Other (2021-2026) & ($ millions)
Figure 20. Global Thyroid Cancer Testing Market Size Market Share by Application in 2025
Figure 21. Global Thyroid Cancer Testing Revenue Market Share by Player in 2025
Figure 22. Global Thyroid Cancer Testing Market Size Market Share by Region (2021-2026)
Figure 23. Americas Thyroid Cancer Testing Market Size 2021-2026 ($ millions)
Figure 24. APAC Thyroid Cancer Testing Market Size 2021-2026 ($ millions)
Figure 25. Europe Thyroid Cancer Testing Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Thyroid Cancer Testing Market Size 2021-2026 ($ millions)
Figure 27. Americas Thyroid Cancer Testing Value Market Share by Country in 2025
Figure 28. United States Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Thyroid Cancer Testing Market Size Market Share by Region in 2025
Figure 33. APAC Thyroid Cancer Testing Market Size Market Share by Type (2021-2026)
Figure 34. APAC Thyroid Cancer Testing Market Size Market Share by Application (2021-2026)
Figure 35. China Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. India Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Thyroid Cancer Testing Market Size Market Share by Country in 2025
Figure 42. Europe Thyroid Cancer Testing Market Size Market Share by Type (2021-2026)
Figure 43. Europe Thyroid Cancer Testing Market Size Market Share by Application (2021-2026)
Figure 44. Germany Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. France Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Thyroid Cancer Testing Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Thyroid Cancer Testing Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Thyroid Cancer Testing Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Thyroid Cancer Testing Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 58. APAC Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 59. Europe Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 61. United States Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 62. Canada Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 63. Mexico Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 64. Brazil Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 65. China Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 66. Japan Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 67. Korea Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 69. India Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 70. Australia Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 71. Germany Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 72. France Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 73. UK Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 74. Italy Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 75. Russia Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 76. Egypt Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 77. South Africa Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 78. Israel Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 79. Turkey Thyroid Cancer Testing Market Size 2027-2032 ($ millions)
Figure 80. Global Thyroid Cancer Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Thyroid Cancer Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Thyroid Cancer Testing Market Size 2027-2032 ($ millions)